Owners, management and financials
CVR: 30815378
Secondary names: PEC-CPH A/S, PHARMACEUTICAL ECONSULTING - COPENHAGEN A/S, PHARMACEUTICAL E-CONSULTING A/S
DKK 6,113,709
Gross profit
Net result: DKK -1,066,960
RUGAARD HOLDING ApS (100%)
CVR · view owners
Steen Otto Rugaard
Board: Pernille Laurberg Rugaard (chair) and 2 members
CVR · view management
Active
Founded 3 September 2007
CVR · view overview
4 employees
CVR · 2018
Director registered: Steen Otto Rugaard
CVR · 14/06/2016
View the full event history
PHARMACEUTICAL ECONSULTING A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2007. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Steen Otto Rugaard. The board consists of Pernille Laurberg Rugaard (chair), Hanne Laurberg Olesen and Steen Otto Rugaard. The company is owned by RUGAARD HOLDING ApS. The company has 4 employees (2018). In 2025, the company reported a gross profit of DKK 6,113,709 and a net result of DKK -1,066,960 compared with DKK -643,853 the year before. Equity in the 2025 report amounted to DKK 5,152,605.
Source: annual report 2025, Danish Business Authority
The financial health of PHARMACEUTICAL ECONSULTING A/S appears to be declining, with consistent losses reported over the past three years, culminating in a profit of -1,066,960 DKK in 2025. Gross profit has shown some fluctuations, peaking at 8,276,389 DKK in 2021 before decreasing to 6,113,709 DKK in 2025. Despite these challenges, the company maintains a reasonable equity position of 5,152,605 DKK, though this has decreased from 7,247,050 DKK in 2022. The lack of disclosed revenue and the trend of declining profitability raise concerns about its competitive position within the industry, which encompasses a range of scientific and technical services.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at drive virksomhed med salg af konsulentydelser og rådgivning indenfor farmaceutisk industri samt anden efter ledelsens skøn dermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/10/2024 – 30/09/2025 | 6.1 mio. | -1.1 mio. | 10.6 mio. | 5.2 mio. | 0 | |
| 202401/10/2023 – 30/09/2024 | 5.5 mio. | -644 t. | 8.8 mio. | 6.2 mio. | 8 | |
| 202301/10/2022 – 30/09/2023 | 5.6 mio. | -384 t. | 8 mio. | 6.9 mio. | 8 | |
| 202201/10/2021 – 30/09/2022 | 6.8 mio. | 780 t. | 8.1 mio. | 7.2 mio. | 8 | |
| 202101/10/2020 – 30/09/2021 | 8.3 mio. | 2.4 mio. | 19.7 mio. | 6.5 mio. | 5 | |
| 202001/10/2019 – 30/09/2020 | 6.9 mio. | 2.3 mio. | 17.1 mio. | 4 mio. | 4 | |
| 201901/10/2018 – 30/09/2019 | 5.3 mio. | 1.2 mio. | 14.1 mio. | 2.7 mio. | 4 | |
| 201801/10/2017 – 30/09/2018 | 3.8 mio. | 1.1 mio. | 11.5 mio. | 2.5 mio. | 4 | |
| 201701/10/2016 – 30/09/2017 | 4.1 mio. | 1.9 mio. | 10.5 mio. | 6.4 mio. | 3 | |
| 201601/10/2015 – 30/09/2016 | 3 mio. | -301 t. | 8.3 mio. | 4.5 mio. | - | |
| 201501/10/2014 – 30/09/2015 | - | 0 | 0 | 0 | - | |
| 201401/10/2013 – 30/09/2014 | - | 0 | 0 | 0 | - | |
| 201301/10/2012 – 30/09/2013 | - | 0 | 0 | 0 | - | |
| 201201/10/2011 – 30/09/2012 | -1.8 mio. | 397 t. | 3.3 mio. | -1.3 mio. | - |
Compared to 1.151 companies in Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of PHARMACEUTICAL ECONSULTING A/S is 30815378.
PHARMACEUTICAL ECONSULTING A/S is owned by RUGAARD HOLDING ApS.
The management of PHARMACEUTICAL ECONSULTING A/S consists of Steen Otto Rugaard.
The board of PHARMACEUTICAL ECONSULTING A/S consists of Pernille Laurberg Rugaard, Hanne Laurberg Olesen and Steen Otto Rugaard, with Pernille Laurberg Rugaard as chair.
In 2025, PHARMACEUTICAL ECONSULTING A/S reported a gross profit of DKK 6,113,709.
PHARMACEUTICAL ECONSULTING A/S had 4 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2025. Gross profit came to DKK 6,113,709, and the net result was DKK -1,066,960.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2024. Gross profit came to DKK 5,538,003, and the net result was DKK -643,853.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2023. Gross profit came to DKK 5,578,646, and the net result was DKK -383,631.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2022. Gross profit came to DKK 6,778,724, and the net result was DKK 779,620.
As of March 27, 2023, Optimal Revision Godkendt Revisionsvirksomhed has been appointed auditor of PHARMACEUTICAL ECONSULTING A/S.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2021. Gross profit came to DKK 8,276,389, and the net result was DKK 2,419,807.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2020. Gross profit came to DKK 6,946,670, and the net result was DKK 2,345,127.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2019. Gross profit came to DKK 5,316,382, and the net result was DKK 1,210,618.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2018. Gross profit came to DKK 3,801,997, and the net result was DKK 1,055,307.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2017. Gross profit came to DKK 4,060,289, and the net result was DKK 1,928,984.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2016. Gross profit came to DKK 2,961,733, and the net result was DKK -301,438.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2015. The net result was DKK 0.
As of June 14, 2016, Hanne Laurberg Olesen has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of June 14, 2016, Steen Otto Rugaard has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of June 14, 2016, Pernille Laurberg Rugaard has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of June 14, 2016, Steen Otto Rugaard is registered as adm. dir. of PHARMACEUTICAL ECONSULTING A/S.
As of April 6, 2016, Hanne Laurberg Olesen has left the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of April 6, 2016, Steen Otto Rugaard has left the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of April 6, 2016, Pernille Laurberg Rugaard has left the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of April 6, 2016, Steen Otto Rugaard has stepped down as director of PHARMACEUTICAL ECONSULTING A/S.
As of December 31, 2015, Hanne Laurberg Olesen has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of December 31, 2015, Jens Christian Pii Olesen has left the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of December 30, 2015, Hanne Laurberg Olesen has left the board of directors of PHARMACEUTICAL ECONSULTING A/S.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2014. The net result was DKK 0.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2013. The net result was DKK 0.
As of April 2, 2014, Optimal Revision Godkendt Revisionsvirksomhed has stepped down as auditor of PHARMACEUTICAL ECONSULTING A/S.
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2012. Gross profit came to DKK -1,783,587, and the net result was DKK 397,364.
As of October 1, 2007, Jens Christian Pii Olesen has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of October 1, 2007, Pernille Laurberg Rugaard has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of September 3, 2007, Optimal Revision Godkendt Revisionsvirksomhed has been appointed auditor of PHARMACEUTICAL ECONSULTING A/S.
As of September 3, 2007, Hanne Laurberg Olesen has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of September 3, 2007, Steen Otto Rugaard has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.
As of September 3, 2007, Steen Otto Rugaard is registered as director of PHARMACEUTICAL ECONSULTING A/S.
As of September 3, 2007, RUGAARD HOLDING ApS is registered as an owner of PHARMACEUTICAL ECONSULTING A/S with an ownership share of 100%.
PHARMACEUTICAL ECONSULTING A/S was founded on September 3, 2007.
Companies in the same industry and area
CVR 42317160
CVR 44388189
CVR 32329241
CVR 38916912
CVR 33026048
